Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia.
Saved in:
| Title: | Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia. |
|---|---|
| Authors: | Kato, Yuki1 (AUTHOR), Udagawa, Hibiki1 (AUTHOR), Matsumoto, Shingo1 (AUTHOR), Izumi, Hiroki1 (AUTHOR), Ohe, Yuichiro2 (AUTHOR), Kato, Terufumi3 (AUTHOR), Nishino, Kazumi4 (AUTHOR), Miyamoto, Shingo5 (AUTHOR), Kawana, Sachiko6 (AUTHOR), Chikamori, Kenichi7 (AUTHOR), Shingyoji, Masato8 (AUTHOR), Sato, Yuki9 (AUTHOR), Takada, Yuji10 (AUTHOR), Toyozawa, Ryo11 (AUTHOR), Azuma, Koichi12 (AUTHOR), Tanaka, Yu1 (AUTHOR), Sakai, Tetsuya1 (AUTHOR), Shibata, Yuji1 (AUTHOR), Sugiyama, Eri1 (AUTHOR), Nosaki, Kaname1 (AUTHOR) |
| Source: | Lung Cancer (01695002). Nov2024, Vol. 197, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2024.107992 |
